Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kaitlyn E Clark"'
Autor:
Clinton O Ogega, Nicole E Skinner, Andrew I Flyak, Kaitlyn E Clark, Nathan L Board, Pamela J Bjorkman, James E Crowe, Andrea L Cox, Stuart C Ray, Justin R Bailey
Publikováno v:
PLoS Pathogens, Vol 18, Iss 1, p e1010179 (2022)
Antibodies targeting the hepatitis C virus (HCV) envelope glycoprotein E2 are associated with delayed disease progression, and these antibodies can also facilitate spontaneous clearance of infection in some individuals. However, many infected people
Externí odkaz:
https://doaj.org/article/ac048e1651254026a9cdd417471e0c03
Autor:
Nicole E. Skinner, Clinton O. Ogega, Nicole Frumento, Kaitlyn E. Clark, Harry Paul, Srinivasan Yegnasubramanian, Kornel Schuebel, Jennifer Meyers, Anuj Gupta, Sarah Wheelan, Andrea L. Cox, James E. Crowe, Stuart C. Ray, Justin R. Bailey
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/924f0e1ce7a94d3cba312821ed1221c4
Autor:
Nicole E. Skinner, Clinton O. Ogega, Nicole Frumento, Kaitlyn E. Clark, Harry Paul, Srinivasan Yegnasubramanian, Kornel Schuebel, Jennifer Meyers, Anuj Gupta, Sarah Wheelan, Andrea L. Cox, James E. Crowe, Stuart C. Ray, Justin R. Bailey
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionEarly development of broadly neutralizing antibodies (bNAbs) targeting the hepatitis C virus (HCV) envelope glycoprotein E2 is associated with spontaneous clearance of infection, so induction of bNAbs is a major goal of HCV vaccine develo
Externí odkaz:
https://doaj.org/article/83059043d7af474d8ff22e9b1d95b230
Autor:
Marian E. Major, Nicole Frumento, Alexander W. Tarr, Johnathan D. Guest, Steven K. H. Foung, Arvind H. Patel, Alexis Figueroa, Jordan Salas, Jonathan K. Ball, Vanessa M. Cowton, Kaitlyn E. Clark, Heidi E. Drummer, Thomas R. Fuerst, Richard A. Urbanowicz, Sarah Cole, Brian G. Pierce, Zhen-Yong Keck, Mansun Law, Justin R. Bailey
Publikováno v:
Gastroenterology. 162:562-574
Background and Aims Development of a prophylactic hepatitis C virus (HCV) vaccine will require accurate and reproducible measurement of neutralizing breadth of vaccine-induced antibodies. Currently available HCV panels may not adequately represent th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970267ca7d83f618757fb8d31409310c
https://doi.org/10.1053/j.gastro.2021.10.005
https://doi.org/10.1053/j.gastro.2021.10.005
Autor:
Andrea L. Cox, Clinton O. Ogega, Nicole E. Skinner, Stuart C. Ray, Nicole Frumento, Kaitlyn E. Clark, Justin R. Bailey, Srinivasan Yegnasubramanian, James E. Crowe
Early development of broadly neutralizing antibodies (bNAbs) targeting the hepatitis C virus (HCV) envelope glycoprotein E2 is associated with spontaneous clearance of infection, so induction of bNAbs is a major goal of HCV vaccine development. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::268b43422420dc07781c6ad220a6c08a
https://doi.org/10.1101/2021.09.11.21263416
https://doi.org/10.1101/2021.09.11.21263416
